SOLITARY pulmonary nodules have caused considerable concern ever since the advent of roentgenography made their detection possible during life. This concern has been heightened in recent years by the ...
Examination of the influence that lymphatic and venous involvement gives consequence of stage I non small-cell lung cancer in new TNM classification. Background: The multidisciplinary lung cancer ...
Patients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate. Study Design: ...
Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.
A solitary lung nodule (SLN) is seen in 1 in 500 chest radiographs. Benign causes include infectious granulomas and hamartomas, and less commonly, rheumatoid nodules, intrapulmonary lymph nodes and ...
Induction cetuximab (C) followed by C, paclitaxel (P), carboplatin (CP) and concurrent radiation (RT) for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) The presence of a ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary nodule stability was frequently observed on veterans’ follow-up CT scans. Other findings on follow-up ...
Please provide your email address to receive an email when new articles are posted on . Diagnostic yield was comparable between navigational bronchoscopy and CT-guided biopsy. Trial investigator ...
Hosted on MSN
Lung nodule clinic opens
Aug. 19 — This week, we spotlight a Rough Draft series that explores the impact of transformation on Atlanta’s west side. Stay tuned for periodic stories on how the development boom is shifting ...
PARIS & SAN JOSE, CALIF.--(BUSINESS WIRE)--Broncus Medical, Inc., developer of diagnostic and therapeutic technologies for lung disease, today announced new data unveiled at the European Respiratory ...
The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results